Global Myopia Treatment Market to Reach $19.57 Billion by 2030: Ortho-K Lenses and Atropine Eye Drops Enhance Myopia Management, Broaden Patient Access
April 10, 2024 03:58 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Myopia Treatment Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Treatment, Age...
Global Retinal Surgery Device Market Report 2024-2030: Detailed Analysis by Product, Application, End-user, and Geographic Region
March 04, 2024 12:13 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Retinal Surgery Device Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report...
Global Intraocular Lens Market Size, Trends and Forecasts Report, 2023 and 2024-2030 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss Meditec, Novartis
February 19, 2024 04:05 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Intraocular Lens Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Vitrectomy Devices Market Forecast to Surge at Rapid Pace Due to Rising Retinal Disorders and Technological Innovations by 2028
January 25, 2024 05:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Vitrectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. ...
Retinopathy of Prematurity Research Reveals Market Insights, Epidemiology, and Forecast to 2032
January 24, 2024 10:49 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Retinopathy of Prematurity - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics Completes Enrollment in Phase 2 Study of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachment
August 28, 2023 07:00 ET
|
ONL Therapeutics
More than 135 patients recruited in four months for Phase 2 study of a single intravitreal (IVT) injection of ONL1204 Ophthalmic Solution as adjunct to standard-of-care surgery Topline data readout...
Global Ophthalmics Partnering Deal Trends, Players and Financials Report 2023
June 06, 2023 03:38 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Ophthalmics Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.Global...
Global Retinal Detachment Disorder Market Size To Exceed USD 3.5 Billion By 2030 | CAGR of 8.3%
April 18, 2023 07:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 18, 2023 (GLOBE NEWSWIRE) -- The Global Retinal Detachment Disorder Market Size is To Grow from USD 1.7 Billion in 2021 to USD 3.5 Billion by 2030, at a Compound...